IMAC Holdings Inc BACK.OQ reported a quarterly adjusted loss of $1.72 per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $-1.20. The lone analyst forecast for the quarter was for a loss of 44 cents per share.
Revenue fell 98.5% to $20.00 thousand from a year ago; analysts expected zero.
IMAC Holdings Inc's reported EPS for the quarter was a loss of $1.72.
The company reported a quarterly loss of $2.03 million.
IMAC Holdings Inc shares had risen by 3.6% this quarter and lost 47.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The average consensus recommendation for the healthcare facilities & services peer group is also "buy"
Wall Street's median 12-month price target for IMAC Holdings Inc is $8.25
This summary was machine generated from LSEG data December 18 at 05:45 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2024 | -0.44 | -1.72 | Missed |
Mar. 31 2024 | -0.91 | -0.35 | Beat |
Dec. 31 2023 | -0.73 | -1.31 | Missed |
Sep. 30 2023 | -0.60 | -2.63 | Missed |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.